Tuesday, September 18, 2007

Lilly's Evista gets Fda Ok for breast cancer

Lilly's Evista gets Fda Ok for breast cancer "Further, postmenopausal women
at high risk for invasive breast cancer will have an alternative therapy for
invasive breast cancer risk reduction". FDA says Eli Lilly and Co.
osteoporosis drug reduces risk of invasive breast cancer in ...

http://www.topix.com/business/biotech/2007/09/lillys-evista-gets-fda-ok-for
-breast-cancer?fromrss=1

Biotech News
http://www.topix.com/business/biotech


Biotech News
AZhttp, Inc.
Biotechnology Marketing

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home